The Prominent Role of miR-942 in Carcinogenesis of Tumors
- PMID: 36133499
- PMCID: PMC9483553
- DOI: 10.4103/abr.abr_226_21
The Prominent Role of miR-942 in Carcinogenesis of Tumors
Abstract
As a family of short noncoding RNAs, MicroRNAs have been identified as possible biomarkers for cancer discovery and assist in therapy control due to their epigenetic involvement in gene expression and other cellular biological processes. In the present review, the evidence for reaching the clinical effect and the molecular mechanism of miR-942 in various kinds of cancer is amassed. Dysregulation of miR-942 amounts in different kinds of malignancies, as bladder cancer, esophageal squamous cell carcinoma, breast cancer, cervical cancer, gastric cancer, colorectal cancer, Kaposi's sarcoma, melanoma, Hepatocellular carcinoma, nonsmall-cell lung cancer, oral squamous cell carcinoma, osteosarcoma, ovarian cancer, pancreatic ductal adenocarcinoma, renal cell carcinoma, and prostate cancer has stated a considerable increase or decrease in its level indicating its function as oncogene or tumor suppressor. MiR-942 is included in cell proliferation, migration, and invasion through cell cycle pathways, including pathways of transforming growth factor-beta signaling pathways, Wnt pathway, JAK/STAT pathway, PI3K/AKT pathway, apoptosis pathway, hippo signaling pathway, lectin pathway, interferon-gamma signaling, signaling by G-protein coupled receptor, developmental genes, nuclear factor-kappa B pathway, Mesodermal commitment pathway, and T-cell receptor signaling in cancer. An important biomarker, MiR-942 is a potential candidate for prediction in several cancers. The present investigation introduced miR-942 as a prognostic marker for early discovery of tumor progression, metastasis, and development.
Keywords: Biomarker; cancer; miR-942; microRNA; microRNA-942.
Copyright: © 2022 Advanced Biomedical Research.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
A Comprehensive Study on Signal Transduction and Therapeutic Role of miR-877 in Human Cancers.Adv Biomed Res. 2023 May 15;12:118. doi: 10.4103/abr.abr_412_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37434921 Free PMC article. Review.
-
The outstanding role of miR-132-3p in carcinogenesis of solid tumors.Hum Cell. 2021 Jul;34(4):1051-1065. doi: 10.1007/s13577-021-00544-w. Epub 2021 May 17. Hum Cell. 2021. PMID: 33997944 Review.
-
Good or not good: Role of miR-18a in cancer biology.Rep Pract Oncol Radiother. 2020 Sep-Oct;25(5):808-819. doi: 10.1016/j.rpor.2020.07.006. Epub 2020 Aug 12. Rep Pract Oncol Radiother. 2020. PMID: 32884453 Free PMC article. Review.
-
Dysfunction of miR-802 in tumors.J Clin Lab Anal. 2021 Nov;35(11):e23989. doi: 10.1002/jcla.23989. Epub 2021 Sep 24. J Clin Lab Anal. 2021. PMID: 34558723 Free PMC article. Review.
-
miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.Neoplasma. 2020 Mar;67(2):215-228. doi: 10.4149/neo_2019_190401N282. Epub 2019 Dec 23. Neoplasma. 2020. PMID: 31884798
Cited by
-
Gastric Cancer in the Era of Epigenetics.Int J Mol Sci. 2024 Mar 16;25(6):3381. doi: 10.3390/ijms25063381. Int J Mol Sci. 2024. PMID: 38542354 Free PMC article. Review.
-
Spotlight on the Expanding Role of miR-647 in Human Cancers.Adv Biomed Res. 2023 Jun 30;12:170. doi: 10.4103/abr.abr_369_22. eCollection 2023. Adv Biomed Res. 2023. PMID: 37564440 Free PMC article. Review.
-
Non-Coding RNAs in Airway Diseases: A Brief Overview of Recent Data.Cancers (Basel). 2022 Dec 22;15(1):54. doi: 10.3390/cancers15010054. Cancers (Basel). 2022. PMID: 36612051 Free PMC article. Review.
References
-
- Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338:1435–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials